Rein Therapeutics
(NASDAQ) RNTX
Rein Therapeutics Financials at a Glance
Market Cap
$32.60M
Revenue (TTM)
$0.00
Net Income (TTM)
$58.88M
EPS (TTM)
$-2.64
P/E Ratio
-0.47
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$1.24
Volume
184,562
Open
$1.33
Price
$1.24
Volume
184,562
Open
$1.33
Previous Close
$1.24
Daily Range
$1.16 - $1.37
52-Week Range
$1.02 - $2.40
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$1.24
Volume
184,562
Open
$1.33
Previous Close
$1.24
Daily Range
$1.16 - $1.37
52-Week Range
$1.02 - $2.40
RNTX News
RNTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rein Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
11
CEO
Brian J. Windsor, PhD
Website
www.reintx.comHeadquarters
Austin, TX 78758, US
RNTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-83%
Return on Capital
-50%
Return on Assets
-1%
Earnings Yield
-2.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$32.60M
Shares Outstanding
26.29M
Volume
184.56K
Short Interest
0.00%
Avg. Volume
134.08K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$65.11M
EBITDA
$28.05M
Operating Cash Flow
$22.29M
Capital Expenditure
$0.00
Free Cash Flow
$22.29M
Cash & ST Invst.
$12.87M
Total Debt
$0.00
Rein Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$32.60M
N/A
Market Cap/Employee
$2.96M
N/A
Employees
11
N/A
Net Income
$5.58M
+4.5%
EBITDA
$5.58M
+4.5%
Quarterly Fundamentals
Net Cash
$4.05M
-77.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.10%
N/A
Return on Invested Capital
-49.56%
N/A
Free Cash Flow
$3.55M
+7.1%
Operating Cash Flow
$3.55M
+7.1%